Rowan Chapman

Rowan brings more than twenty years of experience as an executive business leader. Over her career, she has served on multiple corporate boards and executed numerous partnerships and investments.

She is a co-founder of Initiate Studios, a life sciences incubator founded in 2020, where she partners with entrepreneurs to launch new companies. Previously Dr. Chapman served as Head of Johnson & Johnson Innovation (NYSE: JNJ) for Western North America, Australia, and New Zealand. Prior to that, she led teams at General Electric Company (NYSE: GE), including as Head of Healthcare Investing at GE Ventures and Head of Precision Diagnostics at GE Healthcare. Before GE, she held operational roles in early and growth-stage startups and was a Partner at Mohr Davidow Ventures for over 11 years, gaining extensive experience as an investor and board member for a wide variety of life science technology- and data-enabled companies. She was an early employee at Rosetta Inpharmatics (IPO, then acquired by Merck & Co.) and Incyte Genomics.

Rowan holds a Ph.D. in Biochemistry and Molecular Biology and a BA in Biochemistry from the University of Cambridge, United Kingdom, and carried out post-doctoral research at UCSF.